Clinical trials data
Short Story Recall in dementia and Alzheimer's trials: 91 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names Short Story Recall in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 91
- Name it in a primary outcome, 40%
- 36 of 91
Tests named in the same studies
- 1
Category Fluency39 studies, 15 as a primary outcome
- 2
Digit Span Test37 studies, 12 as a primary outcome
- 3
Trail Making Test35 studies, 13 as a primary outcome
- 4
Verbal Learning27 studies, 11 as a primary outcome
- 5
Symbol Coding26 studies, 15 as a primary outcome
- 6
Verbal Fluency26 studies, 9 as a primary outcome
- 7
Picture Naming Test24 studies, 8 as a primary outcome
- 8
Selective Reminding Task21 studies, 12 as a primary outcome
- 9
Stroop Color-Word Test19 studies, 8 as a primary outcome
- 10
Complex Figure Copy and Recall11 studies, 4 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 2 | 1 |
| 2009 | 3 | 0 |
| 2010 | 3 | 1 |
| 2011 | 4 | 4 |
| 2012 | 3 | 2 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 6 | 1 |
| 2016 | 4 | 3 |
| 2017 | 6 | 1 |
| 2018 | 5 | 4 |
| 2019 | 9 | 4 |
| 2020 | 1 | 0 |
| 2021 | 7 | 2 |
| 2022 | 4 | 2 |
| 2023 | 9 | 3 |
| 2024 | 4 | 1 |
| 2025 | 7 | 2 |
| 2026 | 7 | 1 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 12 studies, 0 as a primary outcome
- Phase 1/26 studies, 1 as a primary outcome
- Phase 219 studies, 11 as a primary outcome
- Phase 2/34 studies, 2 as a primary outcome
- Phase 35 studies, 2 as a primary outcome
- Phase 41 studies, 0 as a primary outcome
- Not applicable37 studies, 12 as a primary outcome
- Observational16 studies, 8 as a primary outcome
Participants per study
- Phase 2117 median, 43 to 188
- Not applicable84 median, 50 to 192
- Observational795 median, 261 to 1,366
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 19 | 117 | 43 to 188 |
| Not applicable | 37 | 84 | 50 to 192 |
| Observational | 16 | 795 | 261 to 1,366 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day7 outcomes, 3 as a primary outcome
- Up to 4 weeks9 outcomes, 4 as a primary outcome
- 1 to 3 months10 outcomes, 2 as a primary outcome
- 3 to 6 months15 outcomes, 7 as a primary outcome
- 6 to 12 months16 outcomes, 3 as a primary outcome
- 1 to 2 years14 outcomes, 5 as a primary outcome
- Over 2 years18 outcomes, 12 as a primary outcome
- No duration given2 outcomes, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
89 of the 91 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting16 studies, 4 as a primary outcome
- Not yet recruiting5 studies, 2 as a primary outcome
- Active, not recruiting7 studies, 4 as a primary outcome
- Completed51 studies, 20 as a primary outcome
- Stopped early4 studies, 1 as a primary outcome
- Status unknown8 studies, 5 as a primary outcome
What they test
- Behavioral23 studies, 9 as a primary outcome
- Drug33 studies, 13 as a primary outcome
- Device8 studies, 0 as a primary outcome
- Dietary supplement5 studies, 2 as a primary outcome
- Procedure2 studies, 2 as a primary outcome
- Diagnostic test2 studies, 0 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Radiation2 studies, 1 as a primary outcome
- Combination product1 studies, 1 as a primary outcome
- Genetic1 studies, 1 as a primary outcome
- Other17 studies, 7 as a primary outcome
- None given10 studies, 6 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States51 studies, 20 as a primary outcome
- Canada11 studies, 4 as a primary outcome
- Spain11 studies, 5 as a primary outcome
- United Kingdom11 studies, 6 as a primary outcome
- Italy10 studies, 2 as a primary outcome
- Australia8 studies, 3 as a primary outcome
- Netherlands8 studies, 2 as a primary outcome
- Sweden7 studies, 2 as a primary outcome
- Belgium6 studies, 2 as a primary outcome
- China6 studies, 1 as a primary outcome
- France6 studies, 3 as a primary outcome
- Finland5 studies, 1 as a primary outcome
39 countries in all. A study with sites in several counts in each; 1 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name Short Story Recall: 41 of 51, 80%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name Short Story Recall | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 14, 27% | 776, 10% |
| Results on ClinicalTrials.gov only | 15, 29% | 1,139, 14% |
| A results paper only | 12, 24% | 1,711, 22% |
| Neither | 10, 20% | 4,327, 54% |
The 91 studies
91 studies match. 36 name Short Story Recall in a primary outcome. Median size 121 participants. Median time to the primary outcome: 12 months.
Loading 91 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 1 | 0 |
| 2007 | 1 | 0 |
| 2008 | 2 | 1 |
| 2009 | 3 | 0 |
| 2010 | 3 | 1 |
| 2011 | 4 | 4 |
| 2012 | 3 | 2 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 6 | 1 |
| 2016 | 4 | 3 |
| 2017 | 6 | 1 |
| 2018 | 5 | 4 |
| 2019 | 9 | 4 |
| 2020 | 1 | 0 |
| 2021 | 7 | 2 |
| 2022 | 4 | 2 |
| 2023 | 9 | 3 |
| 2024 | 4 | 1 |
| 2025 | 7 | 2 |
| 2026 | 7 | 1 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 17, NIH 2, other 72. Interventional 75, observational 16.
As a primary outcomeSecondary or other outcomeShort Story Recall
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07730671 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants121 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07717411 | Start2026 | PhasePhase 3 | ConditionsDementia and Alzheimer's | Participants1,600 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07672977 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants30 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07533084 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Aging, frailty and exercise | Participants265 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07452939 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Delirium, surgery and intensive care | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07233512 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants26 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07210528 | Start2025 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants48 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07200739 | Start2026 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Depression and bipolar disorder | Participants440 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07138677 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07087951 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants70 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06953167 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06946511 | Start2025 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants50 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06775964 | Start2026 | PhasePhase 1/2 | ConditionsDementia and Alzheimer's | Participants12 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06715995 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants52 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06492967 | Start2021 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants1,065 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06375213 | Start2023 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants990 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06335836 | Start2024 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants209 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06254469 | Start2025 | PhasePhase 3 | ConditionsDementia and Alzheimer's | Participants230 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT06163716 | Start2018 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants125 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06072963 | Start2024 | PhasePhase 2 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Obesity and diabetes | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05880849 | Start2023 | PhasePhase 1 | ConditionsDementia and Alzheimer's | Participants15 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05877196 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants216 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05730023 | Start2023 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05631236 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants43 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use Short Story Recall?
91 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 36 of them in a primary outcome: 5% of the condition's 1,673 studies with a cognitive outcome, against 2% of all of them. It is the 9th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with Short Story Recall?
Category Fluency (39 studies), the Digit Span Test (37 studies) and the Trail Making Test (35 studies).
How many participants do phase 2 dementia and Alzheimer's trials that use Short Story Recall enroll?
Half of the phase 2 studies that name it enroll 117 participants or fewer, and the middle half enroll 43 to 188. 19 of them give a size.
When do dementia and Alzheimer's trials measure Short Story Recall?
Half of the primary outcomes that name Short Story Recall are measured within 12 months of the start, and the middle half from 15 weeks to 3 years. 36 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use Short Story Recall have reported results?
41 of the 51 completed studies that name it, 80%, have reported results: 29 posted them on ClinicalTrials.gov, 26 have a results paper linked to the registry record, and 14 did both. The other 10 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run Short Story Recall in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.